Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC

Danielle Brazel,1 Misako Nagasaka1– 3 1Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USA; 3Department of Medicine, St. Marianna University School of Medicine, Kawasaki, JapanCorrespondence: Misako Na...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brazel D, Nagasaka M
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2022-05-01
Colecção:Lung Cancer: Targets and Therapy
Assuntos:
early stage non-small cell lung cancer
epidermal growth factor receptor
adjuvant therapy
osimertinib
disease free survival
overall survival
Acesso em linha:https://www.dovepress.com/deconstructing-adaura-it-is-not-yet-time-to-forgo-platinum-based-adjuv-peer-reviewed-fulltext-article-LCTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados